Format

Send to

Choose Destination
See comment in PubMed Commons below
J Foot Ankle Res. 2010 Mar 2;3:3. doi: 10.1186/1757-1146-3-3.

Heel raises versus prefabricated orthoses in the treatment of posterior heel pain associated with calcaneal apophysitis (Sever's Disease): a randomised control trial.

Author information

1
Cardinia Casey Community Health Service, Southern Health, Cranbourne, Australia. alicia.james@southernhealth.org.au.

Abstract

BACKGROUND:

Posterior Heel pain can present in children of 8 to 14 years, associated with or clinically diagnosed as Sever's disease, or calcaneal apophysitis. Presently, there are no comparative randomised studies evaluating treatment options for posterior heel pain in children with the clinical diagnosis of calcaneal apophysitis or Sever's disease. This study seeks to compare the clinical efficacy of some currently employed treatment options for the relief of disability and pain associated with posterior heel pain in children.

METHOD:

DESIGN:

Factorial 2 x 2 randomised controlled trial with monthly follow-up for 3 months.

PARTICIPANTS:

Children with clinically diagnosed posterior heel pain possibly associated with calcaneal apophysitis/Sever's disease (n = 124).

INTERVENTIONS:

Treatment factor 1 will be two types of shoe orthoses: a heel raise or prefabricated orthoses. Both of these interventions are widely available, mutually exclusive treatment approaches that are relatively low in cost. Treatment factor 2 will be a footwear prescription/replacement intervention involving a shoe with a firm heel counter, dual density EVA midsole and rear foot control. The alternate condition in this factor is no footwear prescription/replacement, with the participant wearing their current footwear.

OUTCOMES:

Oxford Foot and Ankle Questionnaire and the Faces pain scale.

DISCUSSION:

This will be a randomised trial to compare the efficacy of various treatment options for posterior heel pain in children that may be associated with calcaneal apophysitis also known as Sever's disease.

TRIAL REGISTRATION:

TRIAL NUMBER:

ACTRN12609000696291Ethics Approval Southern Health: HREC Ref: 09271B.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center